tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Revenue

Compare
1 Followers

Keymed Biosciences, Inc. Revenue

Keymed Biosciences, Inc. had a revenue of 54.68M in the quarter ending Jun 30, 2024, with 102.74%. This bring the company's revenue in the last twelve months to 95.14M, Increased -74.12%. In the fiscal year ending Dec 31, 2023, Keymed Biosciences, Inc. had annual revenue of 354.10M with 253.87% growth.
Revenue (ttm)
95.14M
Revenue Growth
16.35%
P/S Ratio
31.23
Revenue/Employee
HK$281,475
Employees
1,258
Market Cap
HK$11.06B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023354.10M254.03M+253.87%
Dec 31, 2022100.06M-10.21M-9.26%
Dec 31, 2021110.27M+∞%
Dec 31, 20200.00
Dec 31, 20190.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis